Kymera Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $136M | 5.3M | 25.46 |
| 2023-09-30 | $70M | 5.1M | 13.90 |
| 2023-06-30 | $115M | 5.0M | 22.99 |
| 2023-03-31 | $138M | 4.7M | 29.63 |
| 2022-12-31 | $109M | 4.4M | 24.96 |
| 2022-03-31 | $165M | 3.9M | 42.32 |
| 2021-12-31 | $225M | 3.6M | 63.49 |
| 2021-09-30 | $190M | 3.2M | 58.74 |
| 2021-06-30 | $90M | 1.8M | 48.50 |
| 2021-03-31 | $36M | 933k | 38.86 |
| 2020-12-31 | $24M | 392k | 62.00 |
| 2020-09-30 | $9.5M | 295k | 32.31 |